ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) | WebDisclosure

Basculer en Français

9815	Companies
196869	Keywords
127923	Articles
104690	Press releases

Headlines Articles Press releases ORPHAN SYNERGY EUROPE-PHARMA

Home
Companies
ORPHAN SYNERGY EUROPE-PHARMA

PRESS RELEASE

published on 09/30/2025 at 19:30, 4 months 4 days ago

Renouvellement complet du Conseil d'administration Élection du Dr Markus Cappel en tant que Président du Conseil d'administration
Renouvellement complet du Conseil d'administration d'OSE Immunotherapeutics avec l'élection du Dr Markus Cappel comme Président. Assemblée Générale tenue à Paris. Nouveau Président se félicite de l'avenir prometteur de la Société

Assemblée Générale Conseil D'administration Renouvellement OSE Immunotherapeutics Dr Markus Cappel
BRIEF

published on 09/26/2025 at 07:05, 4 months 9 days ago

Partenariat stratégique pour l'innovation en immunothérapie

Partenariat Stratégique Oncologie Soutien Industriel Innovation Immunothérapie Recherche Collaborative
BRIEF

published on 09/26/2025 at 07:05, 4 months 9 days ago

Strategic Partnership for Innovation in Immunotherapy

Strategic Partnership Oncology Industrial Support Immunotherapy Innovation Collaborative Research
PRESS RELEASE

published on 09/26/2025 at 07:00, 4 months 9 days ago

OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie
Partenariat stratégique entre OSE Immunotherapeutics, Inserm Transfert et Nantes Université pour accélérer l'innovation en immunothérapie. Objectif : transformer découvertes académiques en thérapies de rupture

Partenariat Immunothérapie OSE Immunotherapeutics Inserm Transfert Nantes Université
PRESS RELEASE

published on 09/26/2025 at 07:00, 4 months 9 days ago

OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise

Innovation Partnership Oncology Collaboration Immunotherapy
BRIEF

published on 09/24/2025 at 08:05, 4 months 11 days ago

OSE Immunotherapeutics corrige une erreur de droit de vote avant l'assemblée générale

Droit De Vote Assemblée Des Actionnaires Erreur Matérielle Accusations Sociétés De Procuration
BRIEF

published on 09/24/2025 at 08:05, 4 months 11 days ago

OSE Immunotherapeutics Corrects Voting Rights Error Before General Meeting

Voting Rights Shareholder Meeting Accusations Material Error Proxy Firms
PRESS RELEASE

published on 09/24/2025 at 08:00, 4 months 11 days ago

Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital
OSE Immunotherapeutics corrects material error in total number of shares and voting rights, refutes accusations, and provides clarity on shareholder agreements and proxy advisory recommendations

Correction Proxy Advisory Shareholder Agreements OSE Immunotherapeutics Material Error
BRIEF

published on 09/23/2025 at 22:35, 4 months 11 days ago

OSE Immunotherapeutics répond à la décision du tribunal

Assemblée Générale Droits Des Actionnaires OSE Immunotherapeutics Tribunal De Commerce De Nantes Erreur Relative Aux Droits De Vote
BRIEF

published on 09/23/2025 at 22:35, 4 months 11 days ago

OSE Immunotherapeutics Responds to Court Decision

General Meeting Shareholder Rights OSE Immunotherapeutics Nantes Commercial Court Voting Rights Error

Accesswire

Published on 02/05/2026 at 17:35, 36 minutes ago

Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 1 hour 31 minutes ago

Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 2 hours 26 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 3 hours 1 minute ago

Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 3 hours 21 minutes ago

High Tide Resources Announces Non-Brokered Private Placements

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 17:55, 16 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 31 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 17:40, 31 minutes ago

UV GERMI : MISE À DISPOSITION DE LA NOTE D’INFORMATION ET DU DOCUMENT « AUTRES INFORMATIONS » DANS LE CADRE DE L’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI
Published on 02/05/2026 at 17:05, 1 hour 6 minutes ago

European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels
Published on 02/05/2026 at 16:30, 1 hour 41 minutes ago

Dividend Declaration

Les Echos

Published on 02/05/2026 at 18:06, 4 minutes ago

Aéroports de Paris SA - Actions et droits de vote au 31 janvier 2026
Published on 02/05/2026 at 18:06, 4 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Published on 02/05/2026 at 18:00, 11 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026
Published on 02/05/2026 at 18:00, 11 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 janvier 2026
Published on 02/05/2026 at 18:00, 11 minutes ago

ACM - Press release 2025 results

View all LES ECHOS COMFI WIRE